|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Abbott Laboratories (NYSE: ABT) through any online brokerage.
The latest price target for Abbott Laboratories (NYSE: ABT) was reported by Morgan Stanley on January 27, 2022. The analyst firm set a price target for 151.00 expecting ABT to rise to within 12 months (a possible 20.45% upside). 27 analyst firms have reported ratings in the last year.
The stock price for Abbott Laboratories (NYSE: ABT) is $125.36 last updated Fri Jan 28 2022 20:59:58 GMT+0000 (Coordinated Universal Time).
A quarterly cash dividend of $0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on February 15, 2022 to stockholders of record on January 13, 2022.
Abbott Laboratories’s $Q1 earnings are confirmed for after-market on April 19, 2022.
There is no upcoming split for Abbott Laboratories.
Abbott Laboratories is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.